申请人:BIAL - PORTELA & CA, S.A.
公开号:US20220388999A1
公开(公告)日:2022-12-08
New compounds of formula I are described:
The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.